Murtaza Jafari | Medical and Clinical Biochemistry and Pharmaceutics | Best Researcher Award

Posted on by Innovator Awards

Dr. Murtaza Jafari | Medical and Clinical Biochemistry and Pharmaceutics | Best Researcher Award

Cheragh University of Medical Sciences | Afghanistan

Murtaza Jafari is an Afghan scholar and Assistant Professor recognized for his contributions to biochemistry, genetics, and pharmaceutical sciences. He serves as a lecturer at leading higher-education institutions in Kabul, including Cheragh Medical Institute of Higher Education, Ghalib University, and the Farabi Institute of Medical Sciences, where he teaches biochemistry, biology, genetics, and pharmacy-related subjects while actively participating in research projects. He holds a Doctor of Pharmacy degree from Kabul University and a Master of Science from Persian Gulf University, specializing in biochemical research and nanotechnology-based applications. His academic work includes the synthesis and application of cobalt ferrite magnetic nanoparticles coated with PEG and PEI, focusing on their use in purifying free and genomic DNA, as well as advancing magnetic nanoparticle-assisted DNA extraction methods. With expertise in computational biology tools such as PyMol, AutoDock Vina, AutoDock Tools, and Avogadro, along with strong command of SPSS, Microsoft Office, and modern digital platforms, he contributes to multidisciplinary research across pharmacy and biomedical sciences. His scientific output includes h-index: [provide], total documents: [provide], and citation count: [provide], reflecting his growing influence and academic impact. Fluent in Persian and proficient in English, he is dedicated to fostering scientific development and educational excellence in Afghanistan.

Profile: Google Scholar 

Featured Publications 

Jafari, M. (2022). Microbiological quality (yeast and mold) of dried fruits in Kabul, Afghanistan: A laboratory study. Global Scientific Review, 1, 19–28.

Jafari, M., Shahryar, S., Mohebbi, S., Ahmadi, A., Nazari, R., Haidari, A. R., … (2025). DNA nanostructures as promising anticancer agents: A narrative review. Cancer Treatment and Research Communications, 101029.

Amiri, S. H., Danish, S. M., Azimi, A. W., & Jafari, M. (2024). Gastric cancer incidence among patients referred to Jamhuriat Hospital, Kabul, Afghanistan: A cross-sectional study, 2023. American Journal of Pedagogical and Educational Research, 23.

Tawakuli, Y., Nazari, R., Rasoli, M. R., Jafari, M., & Sultani, F. (2022). Evaluation of narcotics prescribed in surgery: A descriptive study in Kabul, Afghanistan, 2022. Texas Journal of Medical Science, 10, 76–80.

Tawakuli, Y., Jafari, M., Taib, A., & Amiri, S. H. (2022). Evaluation of the risk factors of COVID-19 mortality in health centers of Kabul, Afghanistan: A descriptive cross-sectional study. American Journal of Technology and Applied Sciences, 3, 35–40.

Baofu Zhu | Pharmacology | Research Excellence Award

Posted on by Innovator Awards

Mr. Baofu Zhu | Pharmacology | Research Excellence Award

Guangdong Pharmaceutical University | China 

Zhu Baofu, Ph.D., is a professor and master's supervisor specializing in cosmetic science, natural product chemistry, and supramolecular drug delivery. His research primarily focuses on the extraction, separation, structural modification, and functional application of natural active ingredients, with additional expertise in the self-assembly of supramolecular compounds driven by weak intermolecular interactions. He investigates how these self-assembled systems can be engineered for advanced drug delivery and controlled-release applications, contributing to innovation at the interface of pharmacy, cosmetics, and biomaterials. He has published more than 20 SCI-indexed research articles, secured three invention patents, and led ten scientific research projects funded at provincial and ministerial levels. His academic contributions include co-editing four textbooks related to fragrances, flavors, cosmetic efficacy evaluation, and pharmaceutical sciences, as well as participating in the compilation of a national blue book summarizing China’s achievements in cosmetic science research. His work has been recognized through major awards, including a Second-Class Science and Technology Progress Award at the provincial level. Beyond research, he provides academic leadership through editorial service and participation in professional expert committees, contributing significantly to the advancement of cosmetic science and pharmaceutical innovation in China.

Profile:  Orcid 

Featured Publications 

Li, A., Zhao, J., Zhang, C., Jiang, Q., Zhu, B., & Cao, H. (2023). Lewis acid-promoted three-component cyclization for the construction of functionalized oxazoles. The Journal of Organic Chemistry, 88(1), Article 2c01432.

Jiang, Q., Li, A., Liu, X., Yu, Y., Zhu, B., & Cao, H. (2022). Lewis acid-catalyzed synthesis of polysubstituted furans from conjugated ene-yne-ketones and 1,3,5-triazinanes. The Journal of Organic Chemistry, 87(11), Article 2c00182.

He, J., Yu, Y., Guo, P., Liu, X., Zhu, B., & Cao, H. (2020). Palladium-catalyzed C–N bond formation: A straightforward alkoxymethylation process for the synthesis of the C1 and C3-dialkoxy indoles. ChemistrySelect, 5(48), 2–7.

Liu, W., He, J., Liu, X., Yu, Y., Pei, Y., Zhu, B., & Cao, H. (2020). Controllable site-selective construction of 4- and 5-hydroxyalkyl-substituted imidazoles from amidines, ynals, and water. The Journal of Organic Chemistry, 85(23), Article 0c01715.

Wang, Y., Liu, X., Zhu, B., Guo, P., Pei, Y., He, Q., & Cao, H. (2020). Cu(I)-catalyzed three-component cyclization for the construction of functionalized thiazoles. The Journal of Organic Chemistry, 85(16), Article 0c01381.

Prof. Dr. Ikuro Suzuki – Pharmacology – Best Researcher Award

Posted on by Innovator Awards

Prof. Dr. Ikuro Suzuki - Pharmacology - Best Researcher Award

Tohoku Institute of Technology - Japan

Author Profile 

ORCID 

🎓 Early academic pursuits

Ikuro Suzuki began his scholarly journey at the prestigious university of tokyo, where he earned his ph.d. in march 2008 from the department of advanced interdisciplinary studies, graduate school of arts and sciences. during his doctoral research, he was awarded the esteemed dc1 research fellowship by the japan society for the promotion of science, reflecting his strong potential in advanced scientific exploration. this early phase of his academic development laid a solid foundation in cutting-edge technologies, including power electronics, biomedical engineering, and interdisciplinary innovation.

💼 Professional endeavors

After completing his doctoral studies, suzuki embarked on a dynamic academic career across several renowned institutions. he began as an assistant professor at the institute of biomaterials and bioengineering, tokyo medical and dental university (2008–2010), followed by another assistant professorship at the faculty of applied biological sciences, tokyo university of technology Pharmacology (2010–2014). in 2014, he joined the tohoku institute of technology, where he steadily rose through the ranks—first as a lecturer, then as an associate professor, and now as a full professor in the department of electrical and electronic engineering. concurrently, he has held influential roles including visiting researcher at riken and director of the air research institute.

🔬 Contributions and research focus

Professor suzuki's research integrates the fields of electrical engineering, biomedical systems, and intelligent electronics, with a strong focus on power electronics. his work bridges theory and practical innovation in electronic circuit design, control systems, and biomedical instrumentation. his multidisciplinary approach enables advancements in devices and technologies that Pharmacology support healthcare and automation. more recently, his research has included applications of power electronics in drug discovery systems and smart diagnostics, reflecting a seamless fusion of engineering and life sciences.

🌏 Impact and influence

Suzuki's influence extends beyond academic instruction into national and international research collaborations. his role as director of the air research institute has driven innovation in artificial intelligence and robotics, while his visiting researcher position at riken places him at the forefront of regenerative medicine and drug development technologies. by founding vitrovo inc. in Pharmacology 2023, he further demonstrated his commitment to translating academic innovation into commercial solutions, particularly in the context of advanced electronics and biotechnology. his work continues to contribute to advancements in power electronics and its applications in health tech.

📚 Academic cites

As an academic, suzuki has published numerous peer-reviewed papers in respected journals spanning electronic systems, biomedical engineering, and interdisciplinary science. his citations reflect a growing recognition of his work across fields, particularly in the application of intelligent control systems and power electronics to biomedical applications. his scholarly output is often referenced by peers working on next-generation devices and adaptive systems.

🧭 Legacy and future contributions

With a career that bridges academia, industry, and interdisciplinary innovation, professor ikuro suzuki's legacy lies in his integrative vision of engineering. as he continues to lead in education, research, and entrepreneurship, his future contributions are expected to focus on enhancing the functionality and intelligence of biomedical devices through power electronics, artificial intelligence, and compact embedded systems. he aims to mentor a new generation of engineers capable of navigating the convergence of electronics and life sciences.

Notable Publications 

  • Title: Development of a Microelectrode Array System for Simultaneous Measurement of Field Potential and Glutamate Release in Brain Slices
    Author(s): Aiko Hasegawa, Naoki Matsuda, Ikuro Suzuki
    Journal: Biosensors and Bioelectronics (2025-11)

  • Title: Advanced Neural Activity Mapping in Brain Organoids via Field Potential Imaging with Ultra-High-Density CMOS Microelectrodes
    Author(s): Remi Yokoi, Naoki Matsuda, Yuto Ishibashi, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-05-25

  • Title: Analysis of β Rhythm Induction in Acute Brain Slices Using Field Potential Imaging with Ultra-High-Density CMOS-Based Microelectrode Array
    Author(s): Hiroto Takahashi, Naoki Matsuda, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-04-04

  • Title: Development of a Microelectrode Array System for Simultaneous Measurement of Field Potential and Glutamate Release in Brain Slices
    Author(s): Aiko Hasegawa, Naoki Matsuda, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-04-04

  • Title: Field Potential Imaging in Human iPSC-Derived Cardiomyocytes Using UHD-CMOS-MEA
    Author(s): Naoki Matsuda, Nami Nagafuku, Kazuki Matsuda, Yuto Ishibashi, Tomohiko Taniguchi, Yusaku Matsushita, Norimasa Miyamoto, Takashi Yoshinaga, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-04-04

Prof. Zhiguo Wang – Polypharmacology – Outstanding Scientist Award

Posted on by Innovator Awards

Prof. Zhiguo Wang - Polypharmacology - Outstanding Scientist Award

Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Bidirectional Complications among Chronic Conditions, Jinan University, China - China 

Author Profile

SCOPUS 

ORCID

GOOGLE SCHOLAR

Early academic pursuits 🎓

Zhiguo Wang embarked on his academic journey with a strong foundation in pharmacology, pursuing his studies at Harbin Medical University in Heilongjiang, China. His early work laid the groundwork for a distinguished career focused on understanding chronic diseases and their complex interrelations. His rigorous training and commitment to research established him as a formidable scholar in the field of cardiovascular and chronic disease research.

Professional endeavors 🏢

Throughout his career, Zhiguo has held numerous prestigious positions, demonstrating his leadership in the medical and research communities. He is currently the Director and Professor at the Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Chronic Disease Complex Complications at Jinan University in Guangzhou, China. His role as a chief scientist and professor across various departments at the First Affiliated Hospital of Jinan University reflects his multifaceted expertise. Additionally, he has contributed significantly as a Distinguished Professor at Harbin Medical University and held a visiting professorship at the Montreal Heart Institute in Canada.

Contributions and research focus 🔬

Zhiguo's research focuses on the mechanistic and translational aspects of chronic diseases, particularly the bidirectional complications arising from these conditions. He has pioneered studies that explore the pathophysiology of cardiovascular diseases and their links to metabolic disorders. His work employs innovative Polypharmacology methodologies to investigate the underlying mechanisms of disease progression and to develop effective therapeutic strategies, aiming to improve patient outcomes in chronic disease management.

Accolades and recognition 🏅

Zhiguo Wang has received numerous accolades for his contributions to medical research, including being a Fellow of the American Heart Association (FAHA) and a Polypharmacology Fellow of the European Society of Cardiology (FESC). His recognition as a Marion L. Munro Research Scholar by the Canadian Diabetes Association further underscores his impactful research in chronic disease mechanisms. His extensive publication record in high-impact journals reflects his influence and standing in the academic community.

Impact and influence 🌍

Zhiguo's research has made a significant impact on the understanding of chronic diseases and their complications, influencing both clinical practice and public health strategies. His work is instrumental in bridging the gap between basic science and clinical applications, ultimately contributing to improved therapeutic approaches Polypharmacology for patients suffering from chronic conditions. He is a sought-after speaker and mentor, inspiring the next generation of researchers in his field.

Legacy and future contributions 🔮

As a leader in chronic disease research, Zhiguo Wang’s legacy is built on his commitment to advancing scientific knowledge and improving patient care. His ongoing research aims to unravel the complexities of chronic disease interactions and to foster innovative therapeutic strategies. With a focus on translational research, Zhiguo's future contributions are poised to drive significant advancements in understanding and treating chronic conditions, leaving a lasting impact on the field and enhancing healthcare outcomes globally.

Notable Publications 

Topical GDF11 accelerates skin wound healing in both type 1 and 2 diabetic mouse models  2020(9)

Metformin Shortens Prolonged QT Interval in Diabetic Mice by Inhibiting L-Type Calcium Current 2020(8)

Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis 2020(38)

Increase of late sodium current contributes to enhanced susceptibility to atrial fibrillation in diabetic mice 2019(22)

Systematic analysis of intestinal microRNAs expression in HCC: Identification of suitable reference genes in fecal samples 2019(4)